A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis

A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis

Abstract Background Some composite measures for determining the treatment effects of disease-modifying antirheumatic drugs on remission and low disease activity (LDA) in rheumatoid arthritis (RA) may produce misleading results if they include an acute phase reactant (APR). To inform the choice of ap...

Full description

Bibliographic Details
Main Authors: Kirsten Janke, Corinna Kiefer, Natalie McGauran, Bernd Richter, Dietmar Krause, Beate Wieseler
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Rheumatology
Subjects:
Rheumatoid arthritis
DAS 28
SDAI
CDAI
Boolean approach
DMARDs
Online Access:https://doi.org/10.1186/s41927-022-00314-7

Internet

https://doi.org/10.1186/s41927-022-00314-7

Similar Items